Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Kulkarni

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 10, 2024
ACKR1 gene polymorphisms in Bombay blood group (O<sub>h</sub>) individuals of Indian originRoshan Shaikh, Ghosh Kanjaksha, Vasantha Kashivishwanath, et al.
Cureus|June 2, 2022
Pattern of Treatment Initiation and Outcomes for Patients With Metastatic Non-small Cell Lung Cancer in OntarioJerry W Ding, Abdulkadir A Hussein, Zhong Ren Huang, et al.
Current Drug Delivery|July 14, 2015
Development and Pharmacokinetic Evaluation of New Oral Formulations of DiacereinSagar D Mandawgade, Swati Kulkarni, Arindam Pal, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 22, 2023
Challenges in the transfusion management of a 15-month-old pediatric patient with Bombay blood group phenotypeSheetal Malhotra, Mansi Mulay, Harita Maru, et al.
Laboratory Medicine|May 25, 2026
The silent threat: a true Bombay phenotype with unexpected tolerance to group O-positive incidental transfusionRevathy R Menon, Monali Lokhande, Swati Kulkarni, et al.
American Journal of Clinical Pathology|October 21, 2010
Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clonesJingxin Qiu, Swati Kulkarni, Rameela Chandrasekhar, et al.
BMC Cancer|February 2, 2008
COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situSwati Kulkarni, Deepa B Patil, Leslie K Diaz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer: A Systematic ReviewSwati Kulkarni, Emily T Vella, Nadia Coakley, et al.
The Breast Journal|February 11, 2011
Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsyThaer Khoury, Yousef Zakharia, Wei Tan, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2- Advanced Breast CancerRam Patel, John Mathews, Caroline Hamm, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 10, 2024
ACKR1 gene polymorphisms in Bombay blood group (O<sub>h</sub>) individuals of Indian originRoshan Shaikh, Ghosh Kanjaksha, Vasantha Kashivishwanath, et al.
Cureus|June 2, 2022
Pattern of Treatment Initiation and Outcomes for Patients With Metastatic Non-small Cell Lung Cancer in OntarioJerry W Ding, Abdulkadir A Hussein, Zhong Ren Huang, et al.
Current Drug Delivery|July 14, 2015
Development and Pharmacokinetic Evaluation of New Oral Formulations of DiacereinSagar D Mandawgade, Swati Kulkarni, Arindam Pal, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 22, 2023
Challenges in the transfusion management of a 15-month-old pediatric patient with Bombay blood group phenotypeSheetal Malhotra, Mansi Mulay, Harita Maru, et al.
Laboratory Medicine|May 25, 2026
The silent threat: a true Bombay phenotype with unexpected tolerance to group O-positive incidental transfusionRevathy R Menon, Monali Lokhande, Swati Kulkarni, et al.
American Journal of Clinical Pathology|October 21, 2010
Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clonesJingxin Qiu, Swati Kulkarni, Rameela Chandrasekhar, et al.
BMC Cancer|February 2, 2008
COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situSwati Kulkarni, Deepa B Patil, Leslie K Diaz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer: A Systematic ReviewSwati Kulkarni, Emily T Vella, Nadia Coakley, et al.
The Breast Journal|February 11, 2011
Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsyThaer Khoury, Yousef Zakharia, Wei Tan, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2- Advanced Breast CancerRam Patel, John Mathews, Caroline Hamm, et al.
Pageof 8